Understanding Research on Librela and Joint Health in Dogs

What a scientific review means for you and your dog

Librela (bedinvetmab) is a medication often used to help dogs with osteoarthritis, a painful condition that affects their joints. Many veterinarians use it because it targets a specific pain pathway and can provide relief without the side effects sometimes seen with traditional pain medicines. But as with any new treatment, researchers continue to study how well it works and whether it has any risks.

A peer reviewed scientific article (Farrell et al, 2025; link at bottom of this post) looked closely at reports of possible side effects in dogs receiving Librela. The authors examined information from a large European database that collects reports from veterinarians, pet owners, and manufacturers whenever a dog experiences a problem after taking a medication. This system doesn’t prove the medication caused the problem, but it helps experts look for patterns that may need more investigation.

The reviewers compared reports from dogs receiving Librela with reports from dogs receiving six other commonly used osteoarthritis medications. They noticed that dogs given Librela had higher numbers of reported musculoskeletal problems. These included things like worsened joint pain, ligament injuries, joint swelling, and, in some cases, bone or joint infections. While these problems can happen in any dog with arthritis, the pattern suggested that there may be a connection worth paying attention to.

The team also reviewed nineteen detailed case reports. In these cases, specialists looked more deeply at the dog’s history, symptoms, and timing of events. Many of these reports showed that joint or mobility problems became worse after the dog started Librela. This does not prove cause and effect, but it raises important questions about which dogs may be more at risk.

The article also points out that the FDA in the United States has released warnings about possible joint-related side effects in dogs taking Librela. These warnings do not mean the medication is unsafe for all dogs. Instead, they remind veterinarians and owners to use the medicine carefully and to watch for changes in mobility, comfort level, or behavior.

It is important to understand that this review does not claim Librela should not be used. Many dogs have benefited from it. Instead, the authors encourage more research so we can better understand which dogs are the best candidates and how to reduce potential risks. They also recommend that veterinarians talk openly with pet owners about both the benefits and the possible side effects.

If your dog is using Librela or you are considering it, the most important thing is good communication with your veterinarian. I strongly recommend getting an accurate diagnosis, and baseline bloodwork and radiographs (x-rays) of the potentially arthritic joints before starting this medication. This holds true for cat owners considering Solensia (frunevetmab) a similar drug for cat arthritis management.

Report any changes in how your pet walks, jumps, plays, or gets up from rest. Early recognition of new or worsening problems allows your veterinarian to adjust treatment and keep your dog as comfortable and safe as possible.

Please check out my other blog posts on this medication.

The full article can be found here

https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2025.1581490/full

As research continues, we will learn even more about how to safely manage arthritis in dogs and give them the best quality of life.